Why this cannabis company's shares rocketed 39% higher today

The Althea Group Holdings Ltd (ASX:AGH) share price has been a huge mover on the ASX on Friday. Here's why…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

One of the best performers on the Australian share market on Friday has been the Althea Group Holdings Ltd (ASX: AGH) share price.

The cannabis company's shares were up as much as 39% to 52.5 cents at one stage. Its shares have since given back a good portion of these gains, but still sit higher by 15.5% at 44.5 cents.

Why did Althea's shares rocket higher today?

This morning Althea announced that it has been granted a Manufacture Licence by the Australian Government's Office of Drug Control.

According to the release, the licence provides Althea with authorisation to manufacture extracts and tinctures of cannabis and cannabis resin in accordance with relevant manufacture permits.

Althea's CEO Josh Fegan appeared to be delighted with the news.

He said: "Althea is excited at receiving our Manufacture Licence. Coupled with the existing Medicinal Cannabis Licence, Althea can now proceed with the next phase of planning for our Victorian based production facility. Althea shareholders can look forward to a vertically integrated, seed-to-sale, state of the art medicinal cannabis operation, comparable to that of our Canadian partner Aphria,"

As of yesterday's close, Aphria was valued at a sizeable C$3.8 billion, making it one of the biggest cannabis companies in the world.

In addition to this, Mr Fegan updated the market on the company's patient approvals and prescribing doctors

He advised that: "Patients approved for Althea medicinal cannabis products have quickly surpassed the recent 100 patient milestone, with 127 patients now approved."

There has been similarly solid growth in the number of doctors prescribing its products. These have increased from 42 to 50 during the last couple of weeks.

It is, however, still a long way off its target of 1,000 patient by this time next year. Though, it believes the "comprehensive work we are doing educating mainstream doctors across Australia, makes that a distinct possibility."

Should you invest?

I like what I've seen with Althea since its listing and believe it is up there with Auscann Group Holdings Ltd (ASX: AC8) and Cann Group Ltd (ASX: CAN) as having the best chance to succeed in the fiercely competitive domestic market.

However, whether or not medicinal cannabis actually takes off in Australia, only time will tell.

Because of this and the reasonable amount of success already being baked into their shares, I would suggest investors restrict these cannabis companies to just their watchlists for the time being.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Person pretends to types on laptop drawn in sand.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a disappointing end to the trading week for investors this Friday.

Read more »

A young boy points and smiles as he eats fried chicken.
Share Gainers

3 ASX All Ords shares smashing the benchmark this week

Investors are sending these three ASX All Ords shares rocketing 18% to more than 29% this week. But why?

Read more »

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why Alliance Aviation, BHP, Boss Energy, and Orthocell shares are racing higher

These shares are ending the week on a positive note. But why?

Read more »

Man with backpack spreading his arms out and soaking in the sun.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a disappointing session for investors today.

Read more »

Hands reaching high for a trophy with a sunset in the background.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a nervous hump day session for ASX investors today.

Read more »

Woman with an amazed expression has her hands and arms out with a laptop in front of her.
Share Gainers

Why Collins Foods, DroneShield, Star Entertainment, and Virgin Australia shares are charging higher

These shares are having a good time on hump day. But why?

Read more »

Ten smiling business people wave to the camera after receiving some winning company news.
Share Gainers

Here are the top 10 ASX 200 shares today

ASX investors enjoyed a strong recovery day this Tuesday.

Read more »

A graphic showing a businessman running up a white upwards rising arrow symbolising the soaring Magellan share price today
Share Gainers

CBA shares hit another all-time high. Can they surpass $200 in 2025?

CBA shares have a tailwind pushing up their price that has nothing directly to do with the bank's business performance.

Read more »